Medicare Enrolled

Dr. Michael Heniff, M.D.

Pulmonary Disease · Palos Heights, IL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
11824 SOUTHWEST HWY, Palos Heights, IL 60463
7082776150
In practice since 2006 (20 years)
NPI: 1790724417 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Heniff from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Heniff? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Heniff

Dr. Michael Heniff is a pulmonary disease specialist in Palos Heights, IL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Heniff performed 527 Medicare services across 299 unique beneficiaries.

Between the years covered by Open Payments, Dr. Heniff received a total of $12,069 from 46 pharmaceutical and/or device companies across 699 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Heniff is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 527 Medicare services $12,069 industry payments

Medicare Practice Summary

Medicare Utilization ↗
527
Medicare services
Bottom 38% in IL for pulmonary disease
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
299
Unique beneficiaries
$148
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~26 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Critical care, first 30-74 min
Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient.
418 $176 $315
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
61 $66 $135
Lung volume test using gas dilution or washout
A test that measures the amount of air in your lungs by using a gas dilution or washout method.
18 $9 $160
Pulmonary gas exchange test
A test to examine how well the lungs exchange gases.
18 $7 $160
Expiratory airflow and volume test
A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume.
12 $6 $120
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$12,069
Total received (2018-2024)
Avg $1,724/year across 7 years
Top 17% in IL for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
699
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,069 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$189
2023
$515
2022
$118
2021
$1,847
2020
$2,759
2019
$3,345
2018
$3,296

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$77
Amgen Inc.
$46
Mylan Specialty L.P.
$44
AstraZeneca Pharmaceuticals LP
$22
Top 3 companies account for 88.4% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$2,924
GlaxoSmithKline, LLC.
$1,988
Boehringer Ingelheim Pharmaceuticals, Inc.
$860
Genentech USA, Inc.
$821
Grifols USA, LLC
$543
PFIZER INC.
$519
Sunovion Pharmaceuticals Inc.
$495
Mylan Specialty L.P.
$493
Teva Pharmaceuticals USA, Inc.
$442
Allergan Inc.
$264
ARBOR PHARMACEUTICALS, INC.
$247
Regeneron Healthcare Solutions, Inc.
$247
Amgen Inc.
$210
Novo Nordisk Inc
$166
Novartis Pharmaceuticals Corporation
$148
Merck Sharp & Dohme Corporation
$147
GENZYME CORPORATION
$145
Janssen Pharmaceuticals, Inc
$108
JAZZ PHARMACEUTICALS INC.
$108
Circassia Pharmaceuticals Inc
$104
Takeda Pharmaceuticals U.S.A., Inc.
$98
Philips Electronics North America Corporation
$85
ABBVIE INC.
$84
Insmed, Inc.
$78
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$77
Mallinckrodt LLC
$77
Actelion Pharmaceuticals US, Inc.
$67
Mallinckrodt Hospital Products Inc.
$62
Arbor Pharmaceuticals, Inc.
$61
Baxter Healthcare
$45
Jazz Pharmaceuticals Inc.
$36
Eisai Inc.
$34
Hikma Pharmaceuticals USA
$31
Advanced Respiratory, Inc
$30
E.R. Squibb & Sons, L.L.C.
$28
Lilly USA, LLC
$26
Inogen, Inc.
$19
BAXTER HEALTHCARE
$19
Nabriva Therapeutics, plc
$18
Aytu Bioscience, Inc
$18
Radius Health, Inc.
$18
Eyevance Pharmaceuticals LLC
$18
Gilead Sciences, Inc.
$17
Bayer HealthCare Pharmaceuticals Inc.
$17
AbbVie Inc.
$13
Phadia US Inc.
$13
Top 3 companies account for 47.8% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ANORO · ANORO ELLIPTA · AREXVY · ASMANEX · AVYCAZ · Adempas · Arikayce · BELSOMRA · BREO · BREO ELLIPTA · BREZTRI · BREZTRI AEROSPHERE · BROVANA · BYDUREON · BYSTOLIC · BYVALSON · CHANTIX · CINQAIR · CREON · DALVANCE · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dayvigo · Dexilant · Dymista · ELIQUIS · Edarbi · Edarbyclor · Esbriet · FARXIGA · FASENRA · FORTEO · Fluid Systems - Non Prod Related · Hillrom - Life 2000 Ventilation System · Horizant · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · ImmunoCAP · JANUVIA · LINZESS · LONHALA MAGNAIR · Life 2000 Ventilation System · Mitigare · NUCALA · Natesto · OFEV · OPSUMIT · OPSUMIT MACITENTAN · Ozempic · Perforomist · Prolastin-C · Prolastin-C Liquid · QVAR · SPIRIVA RESPIMAT · STEGLATRO · STIOLTO · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Saxenda · TEZSPIRE · TRELEGY ELLIPTA · TRULICITY · TUDORZA PRESSAIR · The Vest System Model 105 Home Care · Trilogy 100 · Trintellix · Tymlos · UPTRAVI · UTIBRON NEOHALER · Utibron · VIBERZI · VIIBRYD · VRAYLAR · Wellcentive Undiv · XARELTO · XIFAXAN · XOLAIR · XYREM · Xenleta · Xofluza · Xolair · YUPELRI · Yupelri · Zerviate
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a pulmonary disease specialist in Palos Heights?
Compare pulmonary diseases in the Palos Heights area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases within 10 mi
242
Per 100K population
4.7
County median income
$81,797
Nearest hospital
PALOS COMMUNITY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Heniff is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 17% of IL peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Heniff experienced with critical care, first 30-74 min?
Based on Medicare claims data, Dr. Heniff performed 418 critical care, first 30-74 min services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Heniff receive payments from pharmaceutical companies?
Yes. Dr. Heniff received a total of $12,069 from 46 companies across 699 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Heniff's costs compare to other pulmonary diseases in Palos Heights?
Dr. Heniff's average Medicare payment per service is $148. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Heniff) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →